Tempest TherapeuticsTPST
13F holders, Q3 2025 (September 30)16holders −1
3new positions
4sold out
$10.28avg. 13F price*
At the end of Q3 2025, 16 institutions reported holding Tempest Therapeutics Inc. (TPST) in their 13F filings, down 1 from Q2 2025. 3 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($1.7M), Geode Capital Management, LLC ($422K) and BlackRock, Inc. ($402K).
- Company
- Tempest Therapeutics Inc.
- CUSIP
- 87978U207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $248K |
| Exits | 4 | $2.8M |
All 13F filers, Q2 2025 → Q3 2025: 58,768 shares bought and 417,500 shares sold, net −358,732 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Vanguard Group Inc. | 0.00% | Add +20.8% | 162,560 | $1.7M |
| Geode Capital Management, LLC | 0.00% | Add +18.1% | 41,024 | $422K |
| BlackRock, Inc. | 0.00% | No change | 39,068 | $402K |
| FMR LLC | 0.00% | Add +0.0% | 33,226 | $342K |
| DRW Securities, LLC | 0.01% | New | 18,828 | $194K |
| UBS Group AG | 0.00% | Add +1.5% | 11,389 | $117K |
| Belvedere Trading LLC | 0.00% | New | 5,325 | $55K |
| Morgan Stanley | 0.00% | Add +0.1% | 2,108 | $22K |
| Osaic Holdings, Inc. | 0.00% | Reduce -9.8% | 1,655 | $17K |
| CIBC Private Wealth Group LLC | 0.00% | Add +76.9% | 460 | $5K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 292 | $3K |
| SBI Securities Co., Ltd. | 0.00% | No change | 56 | $576 |
| Bank of America Corp. | 0.00% | Add +12.1% | 37 | $381 |
| Parallel Advisors, LLC | 0.00% | No change | 18 | $185 |
| Wells Fargo & Company | 0.00% | New | 3 | $31 |
| BNP Paribas Financial Markets | 0.00% | No change | 3 | $31 |
"% of holder's portfolio" is TPST's weight in each manager's 13F, not the share of Tempest Therapeutics Inc. the manager owns.